SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-21-022553
Filing Date
2021-06-28
Accepted
2021-06-28 17:14:16
Documents
2
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3617
2 EXHIBIT 24 brhc10026331_ex24.htm EX-24 7227
  Complete submission text file 0001140361-21-022553.txt   12186
Mailing Address C/O CYCLERION THERAPEUTICS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address
Mendelsohn Michael (Reporting) CIK: 0001591109 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38787 | Film No.: 211054469

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Issuer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations